相似文献
1
Candida bracarensis bloodstream infection in an immunocompromised patient.
J Clin Microbiol. 2010 Dec;48(12):4677-9. doi: 10.1128/JCM.01447-10. Epub 2010 Sep 29.
2
Identification of a new species, Candida subhashii, as a cause of peritonitis.
Med Mycol. 2009 May;47(3):305-11. doi: 10.1080/13693780802380545. Epub 2008 Sep 16.
3
Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
J Clin Microbiol. 2008 Feb;46(2):443-6. doi: 10.1128/JCM.01986-07. Epub 2007 Dec 12.
4
A novel flucytosine-resistant yeast species, Candida pseudoaaseri, causes disease in a cancer patient.
J Clin Microbiol. 2011 Dec;49(12):4195-202. doi: 10.1128/JCM.05090-11. Epub 2011 Oct 5.
5
Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
Mycopathologia. 2014 Oct;178(3-4):307-14. doi: 10.1007/s11046-014-9778-9. Epub 2014 Jul 15.
6
Candida nivariensis in comparison to different phenotypes of Candida glabrata.
Mycoses. 2014 Dec;57(12):747-53. doi: 10.1111/myc.12264. Epub 2014 Sep 30.
7
Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes.
Int J Antimicrob Agents. 2010 Jan;35(1):85-8. doi: 10.1016/j.ijantimicag.2009.08.009. Epub 2009 Sep 27.
8
Rapid identification of yeasts from positive blood culture bottles by pyrosequencing.
Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):21-4. doi: 10.1007/s10096-010-1045-5. Epub 2010 Aug 28.
9
Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.
J Clin Microbiol. 2013 Jan;51(1):31-9. doi: 10.1128/JCM.01627-12. Epub 2012 Oct 17.
10
Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
Mycopathologia. 2014 Oct;178(3-4):279-83. doi: 10.1007/s11046-014-9800-2. Epub 2014 Aug 15.
引用本文的文献
1
Global Epidemiology of Invasive Infections by Uncommon Species: A Systematic Review.
J Fungi (Basel). 2024 Aug 7;10(8):558. doi: 10.3390/jof10080558.
2
Candidiasis by , and in : Virulence and Therapeutic Responses to Echinocandins.
J Fungi (Basel). 2021 Nov 23;7(12):998. doi: 10.3390/jof7120998.
3
Candida bracarensis, an emerging yeast involved in human infections.
Rev Esp Quimioter. 2021 Oct;34(5):500-501. doi: 10.37201/req/020.2021. Epub 2021 Jul 5.
4
Caenorhabditis elegans as a Model System To Assess Candida glabrata, , and Virulence and Antifungal Efficacy.
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00824-20.
5
Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
PLoS One. 2019 Oct 16;14(10):e0223920. doi: 10.1371/journal.pone.0223920. eCollection 2019.
6
Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.
Folia Microbiol (Praha). 2019 May;64(3):307-312. doi: 10.1007/s12223-018-0655-7. Epub 2018 Oct 25.
7
First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern.
Folia Microbiol (Praha). 2018 Jul;63(4):517-523. doi: 10.1007/s12223-018-0592-5. Epub 2018 Feb 27.
8
Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00170-17. Print 2017 Jul.
9
Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
Mycopathologia. 2016 Dec;181(11-12):871-878. doi: 10.1007/s11046-016-0052-1. Epub 2016 Sep 28.
10
Recent Taxonomic Developments with and Other Opportunistic Yeasts.
Curr Fungal Infect Rep. 2012 Sep;6(3):170-177. doi: 10.1007/s12281-012-0094-x.
本文引用的文献
1
Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.
J Clin Microbiol. 2009 Apr;47(4):1216-7. doi: 10.1128/JCM.02315-08. Epub 2009 Feb 4.
2
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
3
Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits.
J Clin Microbiol. 2008 Oct;46(10):3498-500. doi: 10.1128/JCM.00982-08. Epub 2008 Aug 6.
4
Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
J Clin Microbiol. 2008 Mar;46(3):933-8. doi: 10.1128/JCM.02116-07. Epub 2008 Jan 16.
5
Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
J Clin Microbiol. 2008 Feb;46(2):443-6. doi: 10.1128/JCM.01986-07. Epub 2007 Dec 12.
6
Epidemiology of invasive candidiasis: a persistent public health problem.
Clin Microbiol Rev. 2007 Jan;20(1):133-63. doi: 10.1128/CMR.00029-06.
7
Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata.
Int J Syst Evol Microbiol. 2006 Jan;56(Pt 1):313-7. doi: 10.1099/ijs.0.64076-0.
8
Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.
J Clin Microbiol. 2005 Aug;43(8):4107-11. doi: 10.1128/JCM.43.8.4107-4111.2005.
9
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
Clin Infect Dis. 2004 Aug 1;39(3):309-17. doi: 10.1086/421946. Epub 2004 Jul 15.
10
Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.
J Clin Microbiol. 2002 Aug;40(8):2860-5. doi: 10.1128/JCM.40.8.2860-2865.2002.
Zotero 插件